
New Delhi-based pain management startup Nivaan Care has raised $7 million in a funding round led by early-stage venture capital firm Sorin Investments, with participation from existing investors W Health Ventures, Endiya Partners and Rebright Partners, as per news reports.
The fresh capital will be deployed to expand its clinic footprint, strengthen clinical operations and enhance minimally invasive treatment capabilities.
Founded in 2023, Nivaan Care focuses on non-surgical treatment of chronic pain conditions affecting the back, neck, knees and other parts of the body.
The company operates a multidisciplinary care model combining interventional pain physicians, physiotherapists and care coordinators to deliver personalised, minimally invasive therapies.
The startup currently runs clinics across Delhi-NCR, Mumbai, Jaipur and Lucknow, supported by around 15 specialists. To date, it has conducted over 40,000 patient consultations and performed nearly 5,000 minimally invasive procedures.
Over the next 4 to 5 years, Nivaan plans to scale from 15 clinics to 60–75 centres nationwide.
Interventional pain management remains a nascent specialty in India, with fewer than 200 clinics operating nationwide, compared to 4,000-5,000 in the US. Nivaan Care aims to bridge this significant infrastructure and treatment gap.
“Interventional pain management is a very young specialty in India. It currently does not exist at scale, similar to where IVF was 20-25 years ago. While the US has close to 4,000-5,000 interventional pain management clinics, India has fewer than 200. That is the gap we intend to bridge,” Cofounder and chief executive Nivesh Khandelwal stated ET.
He added that nearly 270 million Indians suffer from chronic pain, a figure rising due to increasingly sedentary lifestyles and reduced physical mobility.
Read More: NSE IPO Inches Closer as SEBI NOC Nears, CEO Confirms!
With fresh capital and a growing nationwide presence, Nivaan Care is positioning itself to build India’s first scaled platform for interventional pain management, addressing a major healthcare gap through non-surgical, technology-enabled clinical care.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 28, 2026, 12:51 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
